At what enterprise value was CAPITOL HEALTH LIMITED acquired in 2024?

During the acquisition of CAPITOL HEALTH LIMITED by INTEGRAL DIAGNOSTICS LIMITED in 2024, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 300M - 700M AUD. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 14.8x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of CAPITOL HEALTH LIMITED when it was acquired by INTEGRAL DIAGNOSTICS LIMITED?

The estimated EV/EBITDA multiple for CAPITOL HEALTH LIMITED is in the range of 5x - 12x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 14.8x. Join our community for free to access full valuation data and industry trends.

What was the revenue of CAPITOL HEALTH LIMITED at the time of the deal?

The revenue of CAPITOL HEALTH LIMITED at the time of the deal is estimated to be in the range of 150M - 250M AUD. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of CAPITOL HEALTH LIMITED during the acquisition?

CAPITOL HEALTH LIMITED's EBITDA is estimated to be in the range of 25M - 50M AUD. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the CAPITOL HEALTH LIMITED acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the CAPITOL HEALTH LIMITED deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.zonebourse.com/cours/action/INTEGRAL-DIAGNOSTICS-LIMI-24543254/actualite/Integral-Diagnostics-Limited-ASX-IDX-a-finalise-l-acquisition-de-Capitol-Health-Limited-ASX-CAJ-48576589/

← DATABASE

Home Database Healthcare & PharmaCAPITOL HEALTH LIMITED

06/2024

CAPITOL HEALTH LIMITED acquired by INTEGRAL DIAGNOSTICS LIMITED

AUSTRALIA Health Providers / Outpatient Care / Radiology EV 300M - 700M AUD

Context

Integral Diagnostics acquired 100% of Capitol Health via a Scheme of Arrangement. The transaction was approved by the ACCC after initial concerns, creating a highly synergistic group. The merger consolidates the fragmented Australian radiology market and provides the combined "MergeCo" with significant scale to invest in teleradiology (IDXt) and advanced AI diagnostic technologies.

CAPITOL HEALTH LIMITED, which reported an EBITDA margin of LOGIN in 2023, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Capitol Health is a leading Australian provider of diagnostic imaging services. It operates a network of 65 clinics across Victoria, South Australia, Tasmania, and Western Australia. The group performs over 1.4 million procedures annually and is a major pure-play radiology provider in the Australian market.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (AUD)

Year

Rev

EBITDA

EBIT

2023

2022

Similar deals in Healthcare & Pharma

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
10/2024	QUALIUM	IMPC (IMAGERIE MEDICALE PARIS CENTRE)	FRANCE	Health Providers	Qualium Investissement is acquiring a 25% minority stake in IMPC from its associate radiologists. This primary LBO transaction follows a strategic period of reflection during which the founding doctors chose to maintain operational and capital control of their group rather than pursuing a majority sale
08/2024	ORLANDO HEALTH	BROOKWOOD BAPTIST HEALTH SERVICES	UNITED STATES	Health Providers	Orlando Health signed a definitive agreement to acquire Tenet Healthcare's majority interest in Baptist Health, the faith-based integrated health system operating across Central Alabama. Upon closing, Orlando Health will become the majority and managing partner of Baptist Health, assuming day-to-day operational management of the system in partnership with Baptist Health System, which retains its minority stake and continues to anchor the organisation's faith-based mission
06/2024	L-GAM / CAPZA / IDIA CAPITAL INVESTISSEMENT	PSV GROUP	FRANCE	Health Providers	L-GAM, CAPZA, IDIA Capital Investissement, and Bpifrance are acquiring a minority stake in PSV Group from its associate physicians. The transaction allows for the entry of a consortium of minority financial partners while ensuring that the associate doctors, who remain majority shareholders, retain full operational and strategic control of the group
01/2024	ARDIAN / BPIFRANCE / MACSF	APRIUM PHARMACIE	FRANCE	Health Providers	Ardian's acquisition of Sagard's majority stake in Healthy Group, the parent company of Aprium Pharmacie, marks the end of a seven-year investment cycle characterized by the institutionalization of the platform and sustained organic growth of over 18% per annum between 2019 and 2023
12/2023	ANDERA PARTNERS	GROUPE IMAGERIE CARDINET	FRANCE	Health Providers	Andera Acto is providing minority financing to Imagerie Cardinet to support its next phase of expansion. The transaction is structured to allow the associate radiologists to maintain a massive majority, representing approximately 95% of the capital
12/2023	ESSLING CAPITAL	X-RAY PHOCEA	FRANCE	Health Providers	X-Ray Phocea, a leading medical imaging group in Southern France, has secured a strategic minority investment from Essling Expansion, alongside Bpifrance and SOFIPACA. Despite this new capital entry, the majority of the group�s shareholding remains in the hands of its 20 associate radiologists, preserving a practitioner-led management model
10/2023	EQT PARTNERS	VETPARTNERS	AUSTRALIA	Health Providers	EQT, through its BPEA Fund VIII, agreed to acquire VetPartners from National Veterinary Associates (NVA), a portfolio company of JAB Holding. The transaction represents a major entry for EQT into the ANZ veterinary services market, following its extensive track record with IVC Evidensia in Europe
08/2023	BAIN CAPITAL	ESTIA HEALTH	AUSTRALIA	Health Providers	Following a five-month bidding process, Bain Capital has entered into a definitive Scheme Implementation Agreement to acquire 100% of the share capital of Australian aged care operator Estia Health Limited
08/2023	QUADRIVIO GROUP	THE PRIVATE CLINIC (TPC)	UNITED KINGDOM	Health Providers	Quadrivio Group has acquired a majority stake in The Private Clinic from BlueGem Capital Partners to serve as a platform for its "Silver Economy" strategy. The industrial logic is anchored in the "healthy longevity" megatrend: as the population ages, demand for aesthetic and wellness treatments among the affluent over-50s is booming
07/2023	MEDIAN KLINIKEN	HESTIA ALLIANCE	SPAIN	Health Providers	MEDIAN Group, backed by Waterland Private Equity, acquired Hestia Alliance, one of Spain's largest private post-acute and mental health care providers, marking MEDIAN's first entry into the Spanish healthcare market

REFERENCES

Valuation range: EV 300M - 700M AUD

Revenue range: 150M - 250M AUD

EBITDA range: 25M - 50M AUD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of CAPITOL HEALTH LIMITED by INTEGRAL DIAGNOSTICS LIMITED are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).